Dual treatment with atazanavir-ritonavir plus lamivudine versus triple treatment with atazanavir-ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trial
Identificadores
Identificadores
Fecha de publicación
2015Título de revista
LANCET INFECTIOUS DISEASES
Tipo de contenido
Artigo